Insider · CIK 0001517897

Drake Lorin

Reports to the SEC for 1 company · SCHAUMBURG, IL

sec.gov

Transactions

Companies

Filings

CIK

0001517897

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-25	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−335 sh	$14.58	−$4,884.3	39,172
2016-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−335 sh	$13.00	−$4,355	31,293
2016-02-22	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+8,214 sh	—	—	39,507
2016-02-22	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Executive VP, Sales	AAward	+17.4K sh	—	—	17,391
2016-02-21	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−449 sh	$14.61	−$6,559.89	31,628
2016-02-18	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−452 sh	$15.16	−$6,852.32	32,077
2015-12-31	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−853 sh	$15.85	−$13.5K	32,529
2015-03-30	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+5,480 sh	—	—	33,382
2015-02-25	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+3,683 sh	—	—	27,902
2015-02-25	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Executive VP, Sales	AAward	+6,840 sh	—	—	6,840
2015-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−293 sh	$28.50	−$8,350.5	24,219
2015-02-21	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−449 sh	$28.50	−$12.8K	24,512
2015-02-18	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−452 sh	$27.22	−$12.3K	24,961
2014-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−290 sh	$21.75	−$6,307.5	25,413
2014-02-21	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−388 sh	$21.84	−$8,473.92	25,703
2014-02-18	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+4,960 sh	—	—	26,091
2014-02-18	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Executive VP, Sales	AAward	+8,865 sh	—	—	8,865
2013-08-12	Sagent Pharmaceuticals, Inc.S Sale	Executive VP, Sales	SSale	−1,000 sh	$23.69	−$23.7K	21,478
2013-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	Executive VP, Sales	FTax Payment	−347 sh	$16.85	−$5,846.95	21,131
2013-02-21	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Executive VP, Sales	AAward	+8,499 sh	—	—	8,499
2013-02-21	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+4,924 sh	—	—	22,478
2012-02-22	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	Executive VP, Sales	AAward	+6,570 sh	—	—	6,570
2012-02-22	Sagent Pharmaceuticals, Inc.A Award	Executive VP, Sales	AAward	+3,680 sh	—	—	17,554

Recent filings

Accepted (ET)
Feb 254
Sagent Pharmaceuticals, Inc.0001562180-16-001814
SEC(opens sec.gov)
Feb 234
Sagent Pharmaceuticals, Inc.0001562180-16-001773
SEC(opens sec.gov)
Feb 224
Sagent Pharmaceuticals, Inc.0001562180-16-001732
SEC(opens sec.gov)
Jan 54
Sagent Pharmaceuticals, Inc.0001209191-16-088448
SEC(opens sec.gov)
Apr 14
Sagent Pharmaceuticals, Inc.0001181431-15-005340
SEC(opens sec.gov)
Feb 274
Sagent Pharmaceuticals, Inc.0001181431-15-003490
SEC(opens sec.gov)
Feb 244
Sagent Pharmaceuticals, Inc.0001181431-15-003280
SEC(opens sec.gov)
Feb 204
Sagent Pharmaceuticals, Inc.0001181431-15-002917
SEC(opens sec.gov)
Feb 244
Sagent Pharmaceuticals, Inc.0001181431-14-008989
SEC(opens sec.gov)
Feb 194
Sagent Pharmaceuticals, Inc.0001181431-14-007821
SEC(opens sec.gov)
Jan 24
Sagent Pharmaceuticals, Inc.0001181431-14-000149
SEC(opens sec.gov)
Aug 134
Sagent Pharmaceuticals, Inc.0001181431-13-044503
SEC(opens sec.gov)
Feb 254
Drake Lorin0001181431-13-012527
SEC(opens sec.gov)

Companies

Sagent Pharmaceuticals, Inc.Executive VP, Sales

Address

C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700

SCHAUMBURG, IL, 60195